glucagon has been researched along with tamoxifen in 5 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, P; Larrey, D; Maurel, P; Michel, H | 1 |
| Diel, P; Fritzemeier, KH; Hegele-Hartung, C; Knauthe, R; Walter, A | 1 |
| Brown-Swigart, L; Dansen, TB; Evan, GI; Rostker, F; Whitfield, J | 1 |
| Chera, S; Damond, N; Herrera, PL; Meda, P; Thorel, F; Thorens, B; Wiederkehr, A; Wollheim, CB | 1 |
| Ackermann, AM; Briker, A; Heller, A; Kaestner, KH; Zhang, J | 1 |
1 review(s) available for glucagon and tamoxifen
| Article | Year |
|---|---|
[Hepatocyte regeneration].
Topics: Anti-Ulcer Agents; Cyclosporine; Epidermal Growth Factor; Glucagon; Hepatocyte Growth Factor; Humans; Insulin; Interleukin-1; Liver Regeneration; Norepinephrine; Stimulation, Chemical; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta | 1993 |
4 other study(ies) available for glucagon and tamoxifen
| Article | Year |
|---|---|
Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus.
Topics: Acute-Phase Proteins; Animals; Base Sequence; Blotting, Northern; Dexamethasone; Estradiol; Ethinyl Estradiol; Female; Gene Expression Regulation, Neoplastic; Glucagon; Insulin-Like Growth Factor Binding Protein 1; Liver; Liver Neoplasms, Experimental; Molecular Sequence Data; Ovariectomy; Polymerase Chain Reaction; Progesterone; Rats; Rats, Wistar; Receptors, Estrogen; RNA, Messenger; S100 Calcium Binding Protein G; Tamoxifen; Tumor Cells, Cultured; Uterus | 1995 |
Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucagon; Immunohistochemistry; In Situ Nick-End Labeling; Insulin-Secreting Cells; Mice; Mice, Transgenic; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Invasiveness; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Pancreas; Proto-Oncogene Proteins c-myc; Tamoxifen | 2006 |
Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.
Topics: Animals; Apoptosis; Cell Count; Diabetes Mellitus, Experimental; Diphtheria Toxin; Glucagon; Glucagon-Secreting Cells; Heparin-binding EGF-like Growth Factor; Hyperglycemia; Hypoglycemia; Insulin; Insulin-Secreting Cells; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Pancreas; Promoter Regions, Genetic; Receptors, Glucagon; Selective Estrogen Receptor Modulators; Signal Transduction; Streptozocin; Tamoxifen | 2011 |
High-fidelity
Topics: 3' Untranslated Regions; Animals; CRISPR-Cas Systems; Diabetes Mellitus, Type 2; Gene Knock-In Techniques; Gene Targeting; Genetic Engineering; Genetic Techniques; Glucagon; Glucagon-Secreting Cells; Islets of Langerhans; Mice; Mice, Transgenic; Tamoxifen; Transgenes | 2017 |